Graft-versus-Host Disease Treatment: Predictors of Survival
Open Access
- 31 December 2010
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 16 (12), 1693-1699
- https://doi.org/10.1016/j.bbmt.2010.05.019
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute and the National Cancer Institute
This publication has 18 references indexed in Scilit:
- A biomarker panel for acute graft-versus-host diseaseBlood, 2009
- Prophylaxis regimens for GVHD: systematic review and meta-analysisBone Marrow Transplantation, 2008
- Impact of graft-versus-host disease on survivalBest Practice & Research Clinical Haematology, 2008
- Study design and endpoints in graft-versus-host diseaseBest Practice & Research Clinical Haematology, 2008
- An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimensBlood, 2006
- Prophylaxis and Treatment of Acute Graft-Versus-Host DiseaseSeminars in Hematology, 2006
- Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation.2006
- Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective studyBlood, 2005
- Novel approaches to the therapy of steroid-resistant acute graft-versus-host diseaseTransplantation and Cellular Therapy, 2004
- Diagnosis and Clinical Management of Chronic Graft-versus-Host DiseaseInternational Journal of Hematology, 2004